Trending News
- Risankizumab (Skyrizi®) Demonstrates Significant Improvements in Clinical Remission and Endoscopic Response in Two Phase 3 Induction Studies in Patients with Crohn’s Disease
- Managing Postoperative Crohn’s Disease Made Easy
- Dispatches from the GUILD Conference 2021
- Teduglutide and Short Bowel Syndrome in Children
- How Common are Pediatric Feeding Disorders?
- Risankizumab (Skyrizi®) Demonstrates Significant Improvements in Clinical Remission and Endoscopic Response in Two Phase 3 Induction Studies in Patients with Crohn’s Disease
- Managing Postoperative Crohn’s Disease Made Easy
- Dispatches from the GUILD Conference 2021
- Teduglutide and Short Bowel Syndrome in Children
- How Common are Pediatric Feeding Disorders?
- Risankizumab (Skyrizi®) Demonstrates Significant Improvements in Clinical Remission and Endoscopic Response in Two Phase 3 Induction Studies in Patients with Crohn’s Disease
- Managing Postoperative Crohn’s Disease Made Easy
- Dispatches from the GUILD Conference 2021
- Teduglutide and Short Bowel Syndrome in Children
- How Common are Pediatric Feeding Disorders?
- This event has passed.
Real World IBD: Dilemmas and Discussion 2019
October 5, 2019
This one-day course will provide clinicians, nurse practitioners and physician assistants with state-of-the-art information on diagnosis and management of inflammatory bowel disease with emphasis on a multidisciplinary approach to patient care. Challenging cases of pouch dysfunction will be presented. Invited speakers are experts from the inflammatory bowel disease clinic, radiology and colorectal surgery.
Format: didactic lectures, panel discussions and Q&A. Active audience participation is strongly encouraged.
6.50 AMA PRA Category 1 Credits™ – maximum